Insider Selling: Concordia International (TSE:CXR) Director Sells 147,000 Shares of Stock

Concordia International (TSE:CXR) (NASDAQ:CXRX) Director John Beighton sold 147,000 shares of the company’s stock in a transaction on Thursday, March 22nd. The stock was sold at an average price of C$0.68, for a total transaction of C$99,960.00.

John Beighton also recently made the following trade(s):

How to Become a New Pot Stock Millionaire
  • On Monday, March 19th, John Beighton sold 34,000 shares of Concordia International stock. The stock was sold at an average price of C$0.75, for a total transaction of C$25,500.00.

Shares of Concordia International stock traded down C$0.02 during trading hours on Thursday, reaching C$0.63. 61,876 shares of the company’s stock were exchanged, compared to its average volume of 112,727. Concordia International has a 1 year low of C$0.58 and a 1 year high of C$2.88.

Concordia International (TSE:CXR) (NASDAQ:CXRX) last released its earnings results on Thursday, March 8th. The company reported C($0.36) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of C$0.08 by C($0.44). The firm had revenue of C$190.77 million for the quarter.

TRADEMARK VIOLATION WARNING: This report was originally posted by Week Herald and is the property of of Week Herald. If you are accessing this report on another publication, it was stolen and republished in violation of US & international copyright laws. The legal version of this report can be read at https://weekherald.com/2018/04/19/john-beighton-sells-147000-shares-of-concordia-international-corp-cxr-stock.html.

About Concordia International

Concordia International Corp., a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. The company operates through two segments, Concordia International and Concordia North America. The Concordia International segment owns or licenses a portfolio of branded and generic prescription products to wholesalers, hospitals, and pharmacies.

Receive News & Ratings for Concordia International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia International and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply